Programs

  • Gene Therapy Programs for Rare Diseases

    ADVANCING DRUG DEVELOPMENT FOR RARE DISEASES. ODYLIA'S TOP THREE PROGRAMS ARE OUR RPGRIP1 AND USH1C GENE THERAPY PROGRAMS, AND BRYDGE SOLUTIONS.
    Geographies
    Not indicated
    Dates
    Jan 1, 2022 – Dec 31, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $673.4K